Condition
Shoulder Prosthesis
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Surface Emg Measurement
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed1
Withdrawn1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04431973Not ApplicableActive Not RecruitingPrimary
Open-label, Prospective, Multicenter, Post-market Study to Evaluate the Reverse Medacta Shoulder System of Total Shoulder Prosthesis.
NCT00284388Not ApplicableWithdrawnPrimary
Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs
NCT00284401Not ApplicableCompletedPrimary
Prosthetic Component Relationship of the Reversed Delta III Total Shoulder Prosthesis in the Transverse Plane of the Body
Showing all 3 trials
Research Network
Common Treatments
- Surface Emg Measurement1
- Medacta Shoulder System1
- Evaluation Of The Placement Of The Delta Prosthesis1
- Simultaneous Controlled Power Measurement1
Active Sponsors
- University Hospital, Ghent2
- University Hospital, Tours1
Top Investigators
University Hospital, Ghent